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Abstract
Background: Porcine reproductive and respiratory syndrome virus (PRRSV) causes a prolonged,
economically devastating infection in pigs, and immune resistance to infection appears variable.
Since the porcine adaptive immune system is not fully competent at birth, we hypothesized that age
influences the dynamics of PRRSV infection. Thus, young piglets, growing 16-20-week-old finisher
pigs, and mature third parity sows were infected with virulent or attenuated PRRSV, and the
dynamics of viral infection, disease, and immune response were monitored over time.
Results: Virulent PRRSV infection and disease were markedly more severe and prolonged in young
piglets than in finishers or sows. Attenuated PRRSV in piglets also produced a prolonged viremia
that was delayed and reduced in magnitude, and in finishers and sows, about half the animals
showed no viremia. Despite marked differences in infection, antibody responses were observed in
all animals irrespective of age, with older pigs tending to seroconvert sooner and achieve higher
antibody levels than 3-week-old animals. Interferon γ (IFN γ) secreting peripheral blood
mononuclear cells were more abundant in sows but not specifically increased by PRRSV infection
in any age group, and interleukin-10 (IL-10) levels in blood were not correlated with PRRSV
infection status.
Conclusion: These findings show that animal age, perhaps due to increased innate immune
resistance, strongly influences the outcome of acute PRRSV infection, whereas an antibody
response is triggered at a low threshold of infection that is independent of age. Prolonged infection
was not due to IL-10-mediated immunosuppression, and PRRSV did not elicit a specific IFN γ
response, especially in non-adult animals. Equivalent antibody responses were elicited in response
to virulent and attenuated viruses, indicating that the antigenic mass necessary for an immune
response is produced at a low level of infection, and is not predicted by viremic status. Thus, viral
replication was occurring in lung or lymphoid tissues even though viremia was not always observed.
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Background
Porcine reproductive and respiratory syndrome virus
(PRRSV) is a member of the enveloped, positive-sense,
single-stranded RNA virus family Arteriviridae [1]. Since its
emergence in the late 1980's, PRRSV has become the most
important pathogen in the swine industry [2,3].
PRRSV is a dynamic agent that evolves by mutation and
recombination [4,5]. Type II isolates, which originated in
North America with strain VR2332 as the prototype, show
extensive variation in virulence and pathogenesis [6-8].
Variation in virulence and level of immune response is
associated with peak levels and duration of viremia [8].
Host animal age also influences the infectious process.
Higher levels of viremia and viral excretion were observed
in young versus older pigs [9,10], and age-dependent var-
iation in disease severity also was observed in young pigs
[11].
These observations suggest that the course of PRRSV infec-
tion and the corresponding anti-PRRSV immune response
might involve variation in both viral strain and host age.
Therefore, we evaluated the virological and immunologi-
cal responses of young, growing, and mature swine to
infection with virulent or attenuated forms of the same
Type II PRRSV to elucidate age-related mechanisms of
resistance to infection.
We observed marked differences in peak and duration of
viremia that were dependent on animal age and viral vir-
ulence. A pronounced humoral immune response to
PRRSV was consistently induced irrespective of animal
age, but cell-mediated immunity was more robust in
mature sows. These findings suggest that animal age, or
physiological maturity, perhaps due to increased innate
immune resistance, strongly influences the outcome of
infection, whereas an effective adaptive immune response
is triggered at a low threshold of infection that is inde-
pendent of age.
Results
Clinical signs and disease
Pigs in all age groups that were infected with virulent
JA142 PRRSV showed clinical signs of PRRS, including
coughing, which were slightly more severe in piglets
(Table 1). Clinical signs were not evident in the attenu-
ated ATP PRRSV-exposed and negative control animals.
Ten pigs inoculated with virulent JA142 PRRSV died dur-
ing the study. Causes of death varied, but only one, a fin-
isher, was attributed to PRRS-related complications. One
untreated piglet also died from a bacterial infection.
Piglets, which were the fastest growing group, showed a
significantly reduced average daily weight gain (ADWG)
at 28 and 63 days when infected with virulent PRRSV
(Table 1). By contrast, inoculation with attenuated ATP
PRRSV had no effect on ADWG in piglets. Twenty-week-
old pigs only showed reduced weight gain at 28 days
when infected with virulent JA142 PRRSV (Table 1). There
was no effect of PRRSV on weight gain in mature sows.
Characteristics of infection
Twenty-six of 30 animals in all age groups receiving viru-
lent, JA142 PRRSV were viremic by day 1 and 100% were
viremic on day 3 (Table 2). Viremia peaked on day 3 in
finishers and sows with mean group titers of about 3.0
log10 TCID50/mL (Figure 1). All animals in these groups
cleared virus below the level of TCID50 detection (≤101)
by day 11 and, with one exception, remained negative to
the end of the study. The exception, a sow, showed a low
titer one time, on day 42. By contrast, viremia in piglets
peaked on day 1 at a significantly higher titer of 4.5 log10
TCID50/mL. All piglets were viremic through 14 days of
Table 1: Effect of PRRSV on clinical signs, clinical scores, and weight gain in pigs of various ages.
Treatment Group
Control ATP JA142
Clinical signs and scores
Piglet Normal Normal Mild cough, days 7-63
Range 3.0-6.3 (peak on day 16)
Finisher Normal Normal Mild, sporadic cough
Range 3.0-4.0 (peak on day 22)
Sow Normal Normal Mild cough, days 12-63
Range 3.0-4.3 (peak on day 12)
Weight gain 0-28 d
Piglet 0.9 0.9 0.4*
Finisher 2.1 2.3 0.9*
Weight gain 28-63 d
Piglet 1.7 1.3 1.1*
Finisher 1.8 1.8 2.0
* Lower average daily weight gain (ADWG), than other groups in the same row, two-sample t-test, p < 0.05.Virology Journal 2009, 6:177 http://www.virologyj.com/content/6/1/177
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infection, and 6 of 7 were viremic at 21 days (Table 2). All
piglets were negative at day 35.
The animals exposed to ATP PRRSV showed a substan-
tially different pattern of viremia. The highest viremic
load was observed in piglets, as was observed with viru-
lent JA142, but virus was not detected until day 8, when 7
of 10 animals were positive. Two animals remained nega-
tive until day 21 (Table 2). Peak viremia, at 3.3 log10
TCID50/mL, occurred on day 21 and viral load declined
slowly and variably. Seven of 10 piglets cleared the ATP
PRRSV by day 42, but sporadic low level positives were
observed for the duration of the study. By contrast, in
growing finishers and sows, only 3 to 4 of 10 animals had
detectable levels of viremia on day 3 (Table 2). Peak mean
group titers were reached on day 3 in finishers (0.73 log10
TCID50/mL) and on day 8 in sows (1.49 log10 TCID50/
mL), but variation in viremia among animals was sub-
stantial. Five finishers and four sows did not show viremia
during the entire study. Viremia was not observed in fin-
ishers or sows after 11 days except for 2 finishers that were
viremic on day 21. All 30 non-challenged control animals
remained PRRSV-negative for the duration of the 63 day
study.
Effect of pig age and viral strain on PRRSV viremia Figure 1
Effect of pig age and viral strain on PRRSV viremia. Data are group mean titers determined by limiting dilution culture 
on MA-104 cells.
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Table 2: Proportion of PRRSV-positive animals by viral isolation on MA104 cells.
Proportion of viremic animals at the indicated days of infection*
Treatment Pig age 0 1 3 8 11 14 21 28 35 42 49 56 63
ATP Piglet 0/10 0/10 0/10 7/10 8/10 8/10 9/10 8/10 8/10 3/10 3/10 2/10 0/10
Finisher 0/10 0/10 3/10 2/10 1/10 0/10 2/10 0/10 0/10 0/10 0/10 0/10 0/10
Adult 0/10 0/10 4/10 5/10 4/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
JA142 Piglet 0/10 9/9 9/9 9/9 9/9 9/9 6/7 4/7 0/6 0/6 0/6 0/6 0/6
Finisher 0/10 8/10 10/10 4/9 0/9 0/9 0/9 0/8 0/8 0/8 0/8 0/8 0/8
Adult 0/10 9/10 10/10 7/10 0/10 0/9 0/9 0/8 0/8 0/8 0/8 0/7 0/6
None Piglet 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
Finisher 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
Adult 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
* All groups with at least one positive animal are shown in bold.Virology Journal 2009, 6:177 http://www.virologyj.com/content/6/1/177
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Viremia also was determined by qRT-PCR; the results were
significantly correlated with viral isolation on MA-104
cells. Spearman correlation coefficients ranged from 0.6 to
0.8 and all were significant (p < 0.05). The qRT-PCR find-
ings confirmed the TCID50/mL results obtained by growth
on MA-104 cells, indicating that both the virulent and
attenuated strains grew equivalently in cell culture. In
young piglets infected with virulent JA142, viremia was
high on day 1 and remained high until day 28, after which
it declined substantially. In finishers and sows exposed to
JA142, viremia was high from day 1 to day 14, then
declined dramatically. Attenuated ATP PRRSV elicited
similar kinetics in young, growing and mature pigs; a
gradual increase until day 21 followed by a gradual
decline in piglets, and brief, low-level viremia in finishers
and sows (data not shown).
Except for day 1, when the copies/mL of viral RNA were
significantly different among all three age groups, JA142-
infected piglets had significantly higher levels of viremia
than both finishers and sows, which were equivalent (t-
test, p < 0.05). ATP PRRSV-treated piglets also had signif-
icantly higher levels of viremia by qRT-PCR than finishers
or sows on days 14 through 42, day 56, and day 63.
Characteristics of the immune response
All pigs showed the same serological response to acute
infection with virulent JA142 regardless of age. As shown
in Figure 2, all group means were positive at day 8 and
peaked at 14 to 21 days, as determined by HerdChek ®
PRRS 2XR ELISA. All groups maintained a positive sam-
ple-to-positive (S/P) ratio for the duration of the study
(Fig. 2). Sows showed a substantial decline in S/P ratio
after 35 days, while piglets showed the highest average S/
P ratio from 49 to 63 days after infection.
Animals inoculated with attenuated ATP PRRSV serocon-
verted at 10 to 14 days, with sows responding on average
more rapidly than finishers and piglets. The response of
sows to attenuated ATP PRRSV peaked at 14 days, whereas
finishers showed increased mean S/P ratios until day 28
and piglets showed a gradual increase in S/P ratio up to 35
days. Thereafter, animals appeared to equalize and then
maintain comparable S/P ratios for the duration of the
study.
In Figure 2, the antibody response of piglets to attenuated
PRRSV appeared to be delayed. To further investigate this
possibility, we examined antibody responses to two spe-
cific viral polypeptides. The kinetics of anti-N responses
were essentially the same among all ages as determined by
HerdChek®  PRRS 2XR ELISA, including the declining
response of sows infected with virulent PRRSV, and the
increasing level of anti-N antibodies from days 49 to 63 in
piglets infected with virulent PRRSV (Fig. 3A). The
response of piglets to attenuated PRRSV was not signifi-
cantly different from that of other age groups. Antibody
responses to a second viral antigen, an antigenic polypep-
tide fragment of nonstructural protein 2 (nsp2Hp),
showed another pattern of reactivity. Here, virulent JA142
Effect of age and viral strain on anti-PRRSV antibody response Figure 2
Effect of age and viral strain on anti-PRRSV antibody response. Data are group mean sample-to-positive (S/P) ratios 
determined by HerdChek® PRRS 2XR ELISA.
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Effect of age and viral strain on antibody responses to specific structural and nonstructural PRRSV proteins Figure 3
Effect of age and viral strain on antibody responses to specific structural and nonstructural PRRSV proteins. (A) 
Anti-nucleocapsid antibodies. (B) Anti-nonstructural protein 2 antibodies. Data are ELISA absorbance values (mean ± 1 stand-
ard deviation) of 10 animals per group. Treatment group legend is shown in panel A.
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PRRSV elicited antibody responses that peaked at 21 to 28
days in all three age groups, then declined slightly in pig-
lets and finishers, and substantially in sows (Fig. 3B).
Attenuated ATP PRRSV elicited lower levels of anti-
nsp2Hp that peaked at 28 days and were maintained for
the duration of the study, or declined slightly in piglets
(Fig. 3B). Anti-nsp2Hp responses were lowest in sows
inoculated with attenuated PRRSV (Fig. 3B), but the same
group showed a strong response in HerdChek® PRRS 2XR
ELISA (Fig. 2). Thus, pigs of all ages mount a humoral
immune response to both virulent and attenuated PRRSV,
though its appearance tends to be more rapid in response
to virulent virus exposure.
Cell-mediated immune responses were examined by IFNγ
ELISPOT for evidence that they could explain anti-PRRSV
immunity that was not accounted for by antibody
responses. Uninfected healthy piglets and finishers
showed very low levels of constitutive IFNγ secretion in
peripheral blood mononuclear cells (PBMC) alone or
after in vitro stimulation with virulent PRRSV, whereas
mitogenic stimulation increased the frequency of secret-
ing cells (Fig. 4A-C, open circles and open squares). The
outcome was similar in piglets and finishers inoculated
with attenuated PRRSV, although in vitro stimulation with
virulent PRRSV increased secreting cell numbers (Fig. 4D-
E). PBMC from piglets and finishers infected with virulent
PRRSV showed the highest levels of IFNγ secretion under
all culture conditions, although there was no consistent
change over time (Fig. 4G-I). Sows under all conditions of
in vivo virus exposure and in vitro culture had higher fre-
quencies of IFNγ secreting cells than did piglets and fin-
ishers (p < 10-6, χ2 test). In other respects the trends were
the same as in piglets and finishers. Thus, cell-mediated
immunity, based on IFNγ secreting cell responses, showed
age-dependent variation that was not observed in anti-
PRRSV antibody responses.
Effect of pig age and PRRSV strain on interferon (IFN) γ-secreting cell frequencies in peripheral blood mononuclear cells  (PBMC) Figure 4
Effect of pig age and PRRSV strain on interferon (IFN) γ-secreting cell frequencies in peripheral blood mono-
nuclear cells (PBMC). Panels A-C, control uninfected pigs (4-5 pigs per group); D-F, pigs inoculated with attenuated ATP 
PRRSV (5-8 pigs per group); G-I, pigs infected with virulent JA142 (10-11 pigs per group). Panels A, D, and G, PBMC cultured 
without stimulation; B, E, and H, PBMC cultured with JA142 PRRSV; C, F, and I; PBMC cultured in presence of phytohemaglut-
tinin (PHA). In each panel, piglets are open squares, finisher pigs are open circles, and sows are closed circles. Asterisk in pan-
els F and I indicate wells with too many cells to count, i.e. >400 per well.
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The level and duration of viremia were significantly
greater in piglets than in finishers and sows. Therefore, we
determined IL-10 levels in serum since it has been impli-
cated in delayed immune responses to PRRSV infection
[12,13]. In piglets infected with virulent PRRSV, IL-10 lev-
els were significantly increased in serum at 8-14 days of
infection (Fig. 5A, p < 0.05). There was no difference
between pigs inoculated with attenuated virus or controls.
IL-10 levels were more variable in finishers and sows, and
there was no difference due to treatment (Fig. 5B, C). In
contrast to piglets, approximately half of the finishers and
sows before virus exposure had measurable levels of IL-10
that were maintained throughout the study. The results
indicate that increased IL-10 levels in serum are associated
with age, and that in piglets, increased IL-10 levels are
related to viral pathogenesis but do not modulate antivi-
ral immunity.
Discussion
We show here that the consequences of PRRSV infection
are highly dependent on pig age. Viral growth is most
extensive in piglets. For both virulent and attenuated
PRRSV, peak viremia and duration were substantially
greater in piglets. Finishers and sows showed the same
pattern of low level viremia for virulent viral infection that
resolved within 2 weeks, and approximately 50% of fin-
ishers and sows inoculated with attenuated PRRSV
showed no viremia. The prolonged period of viremia
commonly associated with PRRSV infection is based on
studies in young pigs (e.g. [5,14,15]). The finding that
viremia is substantially reduced in growing and adult pigs
is novel and indicates that the mechanisms of PRRSV
resistance are developmentally regulated.
The pattern of slowly rising viral titer, delayed peak and
prolonged persistence of viremia observed in piglets given
attenuated PRRSV was previously reported in young pigs
infected with cell-culture adapted PRRSV strain VR2332
[5]. After one passage in vivo, the kinetics of viremia were
equivalent to those observed here for infection of piglets
with JA142 [5]. Attenuated or lowly virulent PRRSV grow
poorly in young pigs [8], but the frequent absence of
viremia in older age pigs has not been documented previ-
ously.
Age- and viral strain-dependent variation in porcine
responses to PRRSV infection was previously reported [9].
However, the significance of the findings in comparison
to the present report is uncertain since mature adult pigs
were not included, quantitative viral loads were not deter-
mined, the viruses were extremely different in genetics as
well as virulence, and there was coincident disease in the
control group.
The restriction in viral growth in older pigs observed here
could be due to differences in innate immunity or in host
cell permissiveness. Since the onset of viremia was the
same or earlier in finishers and sows compared to piglets,
it appears that permissive macrophages are available at all
times. Acute infection of pigs at about 20 weeks of age
does not reduce the abundance of macrophages in lung or
lymphoid tissues [16], therefore it is more likely that sup-
pression of PRRSV infection in older animals is due to
more potent mechanisms of innate resistance.
An alternative possibility is that PRRSV selectively induces
an immunosuppressive response that blocks innate resist-
ance in young pigs. Various studies based primarily on in
vitro cell culture experiments that assess mRNA levels or
secreted cytokines implicate IL-10 induction by PRRSV
infection as a mechanism facilitating viral persistence
[13,17,18]. The data here show that IL-10 concentrations
are significantly and transiently elevated up to 40 pg/mL
in serum of piglets infected with virulent PRRSV. How-
ever, older pigs frequently had higher levels of IL-10, up to
800 pg/mL, before infection and in uninfected controls.
Since the level of IL-10 prior to infection had no effect on
the level of viremia, since peak viremia occurred in piglets
one week before the appearance of IL-10, and since it was
not observed in piglets exposed to attenuated PRRSV, we
conclude that IL-10 production in piglets is a consequence
of viral virulence and pathogenesis, rather than being the
cause of viral persistence.
In contrast to their effects on infection, pig age and viral
virulence had relatively little impact on the antigen-spe-
cific adaptive immune response, even though viremia was
not observed in nearly half (9/20) of juvenile and adult
pigs. Regardless of the viral strain used to challenge pigs,
all animals seroconverted, and all groups showed the
same level of antibody by HerdChek® PRRS 2XR ELISA at
day 35. Variation in the intensity of antibody responses
appeared to be random, since differences in kinetics or
intensity of response determined by one assay were not
reproduced when the same sera were analyzed by another
assay, as demonstrated by comparison of the group
responses to N and nsp2Hp in Figure 3. Animal variation
in the magnitude of immune response to PRRSV and to
various PRRSV proteins has been described previously
and is a common feature of vertebrate adaptive immunity
[8,15,16,19].
Antigen-specific immunological competence is achieved
in pigs by day 74 of gestation, i.e. midway in fetal devel-
opment [20-22]. At 3 weeks of age, piglets show strong
IgM and IgG antibody responses to the protein antigen,
keyhole limpet hemocyanin, and to a variety of PRRSV
proteins following infection [14,15]. Therefore, even if
antigen-specific adaptive immunity is not fully developedVirology Journal 2009, 6:177 http://www.virologyj.com/content/6/1/177
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Effect of pig age and viral strain on IL-10 levels in serum early in infection Figure 5
Effect of pig age and viral strain on IL-10 levels in serum early in infection. Data points are values from individual pig-
lets (A), finishers (B), and sows (C) treated as indicated in the legend (box in panel A).
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in piglets, the failure to achieve more rapid elimination of
viremia does not appear to be related to the adaptive
immune response, as shown in this study and previously
[14-16].
Molecular and cellular mechanisms of innate immunity
to viral infection are extensive, but little is known about
their role in resistance to PRRSV infection. Cellular immu-
nity, mediated by NK cells or other cell types has not been
explored [23]. Absence of IFNα induction early in infec-
tion is well described and believed to help explain pro-
longed infection [24-26]. However, there are no
comparative studies of differences in interferon responses
or other innate immune mechanisms that might explain
the marked age-dependent differences in infection out-
comes in young versus older pigs. Interleukin-10, which
has been suggested to suppress anti-PRRSV immunity
[13,17,18], has been shown to suppress inflammatory
cytokine production and reduce disease severity in a swine
model of bacterial pleuropneumonia [27]. However, the
data reported here are more consistent with IL-10 produc-
tion being a consequence of virulent infection rather than
a cause of prolonged infection.
Differences in circulating IFNγ secreting cells did not
account for differences in age-dependent infection; rather,
they suggested that finishers were more similar to piglets,
a conclusion that is in contrast to the similarity between
finishers and sows in control of viral infection. The inter-
pretation of IFNγ secreting cell frequencies is confounded
since IFNγ in pigs is produced by a wide variety of cell
types, including activated CD8+ T cells [28], natural killer
T cells [29], and γδT cells [30], in addition to type 1 CD4+
T cells.
The lack of a substantial effect of pig age on antigen-spe-
cific immune responses in contrast to a significant age-
dependent effect on the kinetics of infection supports the
concept that control of PRRSV viremia may not be
dependent on adaptive immune responses [14,16,23,31].
Interestingly, lactate dehydrogenase elevating virus, an
arterivirus closely related to PRRSV, causes a persistent
viremia in mice that is not controlled by a neutralizing
antibody response [32]. It has been proposed that infec-
tion is controlled, though not eliminated, by a deficiency
in permissive macrophages. A similar phenomenon might
operate to control PRRSV viremia, which occurs before
neutralizing antibody responses are observed [15,18],
possibly through interference with virus binding to its
CD163 receptor on macrophages [31].
Lastly, it was notable that all groups of pigs exposed to
PRRSV developed equivalent adaptive antibody and cell-
mediated immune responses irrespective of the kinetics or
magnitude of viremia. This observation suggests that the
requirements of antigenic mass and mode of presentation
for an immune response to PRRSV are met at a low level
of infection in the absence of viremia. Therefore, viremia
may be an insensitive indicator of infection by lowly viru-
lent or attenuated PRRSV strains, especially in growing
and mature swine. Resolution of viremia appears not to
require an adaptive immune response based on the find-
ings here and elsewhere [14-16]. While adaptive immu-
nity most likely is essential for protection against future
challenge, control of primary infection appears to rely pri-
marily on innate mechanisms of immunity that are more
effective at about 15 weeks of age and older.
Conclusion
We show that animal age, likely due to increased innate
immune resistance, strongly influences the outcome of
acute PRRSV infection, whereas an effective antibody
response is triggered at a low threshold of infection that is
independent of age. Prolonged infection was not due to
IL-10-mediated immunosuppression, and PRRSV did not
elicit a specific IFN γ response, especially in non-adult ani-
mals. Equivalent antibody responses were elicited in
response to virulent and attenuated viruses, indicating
that the antigenic mass necessary for an immune response
is produced at a low level of infection, and is not predicted
by viremic status. Thus, viral replication was occurring in
lung or lymphoid tissues even though viremia was not
always observed.
Methods
Study Design
Ninety healthy, PRRS-negative pigs, consisting of 30
three-week-old weaned piglets, 30 16-20-week-old mixed-
sex finisher pigs, and 30 nonpregnant, third parity (± 1)
sows, were obtained from a PRRSV-free, genetically uni-
form, commercial source herd. Animals were confirmed
PRRS-negative by HerdChek® PRRS 2XR ELISA (IDEXX
Laboratories Inc., Westbrook, ME) and given a Myco-
plasma hyopneumoniae vaccine (Boehringer Ingelheim, St.
Joseph, MO) on day 0 of the study. Animals were rand-
omized by weight, within each age group, into 3 groups of
10 animals for infection with attenuated Ingelvac® PRRS
ATP (Boehringer Ingelheim Vetmedica Inc., St. Joseph,
MO), or virulent JA142 PRRSV (vaccine parental isolate,
kindly provided by William Mengeling, National Animal
Disease Center, Ames, IA) or received diluent only (Table
3). Viral isolates were diluted in Eagle's Minimal Essential
Medium (EMEM) (SAFC Biosciences, Lenexa, KS) con-
taining 4% fetal bovine serum (FBS) (SAFC Biosciences,
Lenexa, KS) to approximately 3.0 ± 0.5 log10 TCID50/mL,
as determined by titration on MA-104 cells [33]. Treat-
ments were administered as a 1 mL intranasal inoculation
and a 1 mL intramuscular injection. As the experiment
was not a vaccine evaluation study, the Ingelvac® ATP virus
was not taken from a vaccine formulation and the doseVirology Journal 2009, 6:177 http://www.virologyj.com/content/6/1/177
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and route did not follow USDA-approved label recom-
mendations.
All animals were bled using Vacutainer® serum separation
tubes (BD Biosciences, Franklin Lakes, NJ). Serum sam-
ples were aliquoted and stored at -70°C until use.
Viremia quantification
Ten-fold serial dilutions were carried out to a final dilu-
tion of 10-7 and four replicates of each dilution were
plated on 96-well plates containing three-day-old MA-104
cells. After incubation at 37°C with 4.5% CO2 for eight
days, wells were examined microscopically for cytopathic
effect (CPE). Titer was determined as described [33].
RNA extractions and qRT-PCR were performed as
described [8]. Briefly, RNA was isolated by spin-column
chromatography (QIAamp Viral RNA Mini-Kit, Qiagen
Inc., Valencia, CA) and qRT-PCR was performed using a
kit for quantitative detection of PRRSV in serum (Tetra-
core Inc., Gaithersburg, MD). Results were reported as
viral genome copies per mL.
Serological assays
Seroconversion was quantified as S/P ratios using the
HerdChek® PRRS 2XR ELISA according to the manufac-
turer's instructions. Protein-specific ELISA was performed
as described [19,34]. Interleukin-10 levels were deter-
mined with a commercial ELISA kit (Biosource Interna-
tional, Camarillo, CA) following the manufacturer's
instructions.
Cell-mediated immune assay
Interferon γ secreting cells were enumerated in PBMC by
ELISPOT as described (Xiao et al. 2004). PBMC were cul-
tured at 5 × 105 cells per well and were stimulated with
PRRSV strain JA142 at 2 × 105 TCID50 per well.
Body weight
Each pig was weighed on days 0 and 63 of the study, using
a calibrated, portable, electronic weigh-bar scale (Weigh-
Tronix™ model 615XL, Weigh-Tronix Inc., Fairmont,
MN). Three-week-old piglets and finishers were also
weighed on day 28.
Clinical scores
Animals were observed daily for clinical condition. Indi-
vidual scores for respiratory signs, coughing, and behavior
were recorded on a scale from 1 (healthy) to 4 (most ill).
A healthy pig received a daily score of 3, whereas a dead
pig scored a 12. Animals that died prior to the end of the
study were necropsied, evaluated for cause of death, and
had samples collected for submission to the Iowa State
University Diagnostic Lab for confirmation via pathologi-
cal investigations.
Statistical analyses
Group mean data for TCID50, qRT-PCR, and IDEXX ELISA
results was analyzed among age groups, and treatment
type for statistical significance using the Kruskal-Wallis
non-parametric ANOVA and individual comparisons
were analyzed by the Wilcoxon two-sample t-test. Spear-
man coefficient correlation was used to compare the
TCID50 and qRT-PCR parameters. A p value < 0.05 was
considered as statistically significant.
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